Reliability and Validity of the NCS (NCS-R)-Chinese Version
CompletedNot applicableNCT03494218
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study was to translate the NCS from English into Chinese and determine the validity of this Chinese version.
Study details
- Official title
- Reliability and Validity of the Nociception Coma Scale (-Revised)-Chinese Version
- Conditions
- Minimally Conscious State
- Vegetative State
- Interventions
- Diagnostic test: Nociception Coma Scale (NCS)
- Sponsor
- Hangzhou Normal University
- Start date
- 2017-10-28
- Primary completion
- 2018-02-02
- Sex
- All
- Age range
- from 19 Years to 53 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age ≥ 18 years old; * no administration of neuromuscular blockers or sedation within the 24 hours of enrolment; * the presence of periods of eye opening (indicating wakefulness and rest cycles); * a diagnosis of VS or MCS, based on more than 4 times behavioral assessment performed using the Coma Recovery Scale-Revised within 2 weeks. Exclusion Criteria: * Coma; * documented history of prior brain injury; * psychiatric or neurologic illness; * neuromuscular blocking agents or sedative drugs administered within the prior 24 hours; * no documented history of a prior coma, critical illness or unstable medical condition; * upper limb contusions, fractures (based on the imaging examination) or flaccid paralysis (by using noxious stimuli to upper limbs, motor sub-scale scores \<1).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03494218